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Abstract-Interaction of a wide range of central nervous system (CNS) drugs with the transport of 
5-hydroxytryptamine (5-HT) and norepinephrine (NE) into synaptosomes from cerebral cortex was 
investigated. By determining the effect on Na,K-ATPase, the interaction of these drugs with the synaptic 
transport of Naf and K + was also assessed. Although of different numerical value, the order of 
potency of the drugs in inhibiting the uptakes of both biogenic amines was comparable. Furthermore, 
similar inhibition constants were obtained for the low affinity uptake of 5-HT and the uptake of 
NE. Desipramine and amphetamine strongly inhibited both uptake processes. The narcotic drugs dis- 
played a wide range of inhibitory potency. An exceptionally strong, but not stereospecific, effect was 
obtained with levorphanol, which inhibited 5-HT uptake with a Ki of 0.7 PM. While methadone and 
pentazocine had inhibition constants between 20 and 50pM, morphine, codeine and naloxone were 
markedly weak inhibitors with K, values extending into the mM range. The uptake of both 5-HT 
and NE was strongly inhibited by quinacrine. Among the drugs investigated, only methadone showed 
substantial inhibition of synaptosomal Na,K-ATPase. The reversible inhibition of the enzyme by the 
drug was diminished at concentrations of Na+ and K+ reflecting synaptic discharge. The drug partially 
bound to the ouabain site of Na,K-ATPase and also inhibited the Mg-activated component. The 
feasibility and experimental conditions were established for using a modified crude mitochondrial frac- 
tion as synaptosomal preparation to study transport processes in general and the uptake of biogenic 
amines in particular. 
Various central nervous system (CNS) drugs may owe 
their pharmacologic action to an interaction with the 
synaptic uptake of biogenic amines [I, 23. Accord- 
ingly, a number of studies were conducted on the in- 
hibition by selected CNS drugs of the uptake of 
5hydroxytryptamine (5-HT) [3-6], as well as dopa- 
mine (DA) and norepinephrine (NE) [7-111. How- 
ever, a comparison and unequivocal interpretation of 
the results of these experiments are hampered by the 
manifold approaches in investigating and presenting 
the inhibitory potencies of the drugs, as well as by 
the limited selection of compounds included in a 
given study. An additional difficulty in evaluating the 
hitherto presented information is created by the dif- 
ferent sources of synaptosomes, ranging from whole 
brain to several discrete areas of the cerebrum. 
In addition to the uptake of biogenic amines, the 
transport of Na+ and K+ across the presynaptic 
membrane represents another major process of trans- 
location in the synaptic cleft. The molecular 
mechanism for the active transport of monovalent 
ions involves the Na,K-ATPase. This enzyme is as- 
sociated with cell membranes and is particularly 
active in excitable tissues [12]. Its presence was de- 
scribed and its activity characterized in synaptosomes 
1131. The effects of a limited selection of CNS drugs, 
particularly tricyclic antidepressants, on synaptoso- 
ma1 Na,K-ATPase were previously investigated 
[14.15]. 
Although reports on uptake processes in synapto- 
somes are manifold, there is a lack of information 
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on criteria which have to be fulfilled by isolated 
synaptosomal preparations in order to render them 
suitable for the study of transport processes. 
Against this background, and within our interest 
in mechanisms of cellular drug transport [l&19], it 
was decided to investigate the interaction of a wide 
selection of CNS drugs with the uptake of biogenic 
amines in synaptosomes isolated from one discrete 
area of the brain, the cerebral cortex. Another goal 
of this study was to determine the effects of the drugs 
on the synaptosomal Na,K-ATPase at concentrations 
of the two ions which reflect both normal and dis- 
charge states in the synaptic cleft. Finally, the study 
was to re-evaluate experimental conditions for investi- 
gating transport processes in synaptosomal prep- 
arations. 
MATERIALS AND METHODS 
Materials. The drugs used in this study were kindly 
provided by Drs. H. H. Swain and J. H. Woods, 
Department of Pharmacology, The University of 
Michigan Medical School. Tritium-labeled (G) 5-HT, 
DA and NE as well as Protosol were obtained from 
Amersham/Searle Corp., Arlington Heights, Ill., Mal- 
linckrodt Chemical Works, St. Louis, MO. and New 
England Nuclear Corp., Boston, Mass. respectively. 
Ficoll and bovine serum albumin (BSA), as well as 
the biochemicals used in the assay of acetylcholines- 
terase (AChE), succinate dehydrogenase (SDH), lac- 
tate dehydrogenase (LDH) and Na, K-ATPase, were 
purchased from Sigma Co., St. Louis, MO.. or 
Boehringer-Mannheim Corp., New York, N.Y. All 
other chemicals were of reagent grade. 
Isolation of synaptosowd preparations. The synap- 
tosomal preparation was isolated from cortices of 
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male Sprague-Dawley rats weighing 18Og. The pro- 
cedure adapted was a modification of the method of 
Autilio et (I/. [20]. The preparation of tissue was car- 
ried out at 4 The cerebral cortices were dissected 
free of white matter and homogenized in 0.32 M su- 
crose at a concentration of IO:;, (w/v). The disruption 
of tissue was carried out at 500 rev/min in a Pottery- 
Elvehjem homogenizer equipped with a Teflon pestle. 
After centrifugation at lOCOg for IOmin, the pellet 
containing nuclei and cell debris was discarded and 
the supernatant centrifuged at 15,OOOg for 20 min. 
The resulting pellet, representing the crude mitochon- 
drial fraction (CM), consisted of a relatively loose, 
light-colored layer on top of a firm yellow portion 
at the bottom of the centrifuge tube. The upper part 
of the pellet was carefully resuspended and decanted, 
leaving the bottom layer undisturbed. The suspension 
of the latter was referred to as modified crude mito- 
chondrial fraction (MCM) and was predominately 
used in this study as the synaptosomal preparation. 
In separate experiments, purified synaptosomes 
were obtained by fractionating the initial tissue 
homogenate using density gradient centrifugation 
according to Autilio et cl/. [20] or Gray and Whit- 
taker [21]. 
Isolrrtion o/’ r,litochondrirr. In a number of exper- 
iments, mitochondria from cerebral cortices of rats 
were isolated according to several procedures 
reported to result in little contamination by other 
organelles, particularly synaptosomes [22%25]. 
Chara~te~i~rrtior~ (?f‘ MCM ji~ction. The activity of 
AChE was determined according to the method of 
Ellman et rrl. [26]. The procedure is based on the 
cleavage of acetylthiocholine iodide and the deter- 
mination of absorbance at 413 nm of the formed 
anion, 5-thio-2-nitrobenzoic acid. The reaction was 
started by the addition of an aliquot of the MCM 
fraction suspended in 0.32 M sucrose and correspond- 
ing to 0.02 to 0.10 mg protein. 
The determination of SDH activity was carried out 
by the method of King [27], which utilizes the oxi- 
dation of succinate in the presence of 2,6-dichloro- 
phenolindophenol and phenazine methosulfate. The 
reduction of indophenol is followed at 600nm. The 
reaction was initiated by the addition of an aliquot 
of the MCM fraction, corresponding to 0.02 to 
0. IO mg protein. 
The activity of LDH was determined by measuring 
the initial rates of pyruvate reduction coupled to a 
decrease in fluorescence of reduced nicotinamide 
adenine dinucleotide (NADH). Final concentrations 
in the assay medium were: imidazol.HCI (pH 7.4) 
20 mM : pyruvate. 1 mM; NADH, 0.01 mM; BSA, 
0.02”,,. For the determination of total LDH in the 
MCM fraction. an aliquot of the suspension in 0.32 M 
sucrose was frozen four times at -70 and thawed, 
centrifuged at 35,OOOg for 5 min, and an aliquot of 
the supernatant used to measure enzyme activity. For 
estimation of LDH release during storage of the 
MCM fraction. an aliquot of the suspension in 
0.32 M sucrose was added to 2 ml of the buffer 
medium used in the uptake experiments. After incuba- 
tion for 15 min at 20”. the suspension was centrifuged 
at 35,OOOg for 5 min and the LDH activity in the 
supernatant determined. 
The cellular concentrations of Na+ and K+ were 
determined by flame photometry. with LiCl as inter- 
nal standard [28]. After various times of storage at 
0 , aliquots of the MCM fraction in 0.32 M sucrose 
corresponding to about 3 mg protein were added to 
2 ml buffer medium. After incubation for 15 min at 
20’. the suspension was centrifuged at 35.000// for 
5 min. The pellet was washed three times by SLIS- 
pension in 0.32 M sucrose and renewed ccntri- 
fugation. The resulting pellet was digested at room 
temperature overnight with 50~1 cont. HNOJ. After 
the addition of 5 ml of 15 mEq/l. LiCI, the concen- 
trations of Nat and K’ were determined in a Ilame 
photometer. 
Condifions ,ftir uptcrku .sturlies. The MCM fraction 
was prepared as described above by suspending the 
upper, loose portion of the CM pellet in 3-4 ml of 
0.32 M sucrose, pH 7.4. The suspension was kept on 
ice and, as needed, lOO/‘l of it was transferred to 
2.15 ml buffer medium, containing the drugs the 
effects of which were investigated. The buffer medium 
had previously been equilibrated with 0, at 20 and 
contained the following final concentrations (mM): 
Tris. 35; NaCI, 100: KCI. 10; MgS04. 1.2: KH,PO,, 
1.2; NaHCO,, 1; glucose, 10; and sucrose. 25. The 
pH of the medium was adjusted to 7.4 with HCI. 
The determined tonicity of the buffer medium was 
317 mOsM. After incubating the suspension for 5 min 
at 20 , 250~1 of a solution of radiolabeled biogenic 
amine in the buffer medium was added and all the 
samples were incubated for a time between 2 and 
5 min with gentle shaking under OZ. The incubation 
was terminated by filtering I-ml aliquots on Reeve 
Angel ultrafine glass fiber disks which initially were 
repeatedly swirled in fresh portions of (X9”,, NaCl. 
The material on the filter was washed with 25 ml of 
ice-cold 0.9”,, NaCI. Total filtration time was 
20-30 sec. The filters were transferred to scintillation 
vials, digested with 0.4 ml Protosol at 60 for I hr 
and cooled to room temperature. Toluene-based scin- 
tillation fluid was then added and the radioactivity 
determined in a liquid scintillation spectrometer. 
To estimate nonspecific interactions with biologic 
material, control experiments were carried out with 
synaptosomal preparations previously repeatedly 
frozen at -70 and thawed. or sonicated 3 x 30sec 
at 0 using a microtip at setting 6 of a Branson cell 
disruptor, model Wl40. 
AS.SU~ c$ Ntr. K-ATPose. The activity of this 
enzyme was determined by measuring the catalyzed 
release of inorganic phosphate (Pi) from ATP. The 
determination of Pi was carried out enzymatically uti- 
lizing phosphorylasc LI. phosphoglucomutase and glu- 
cose 6-phosphate dehydrogenase 1291. The assa) of 
Na. K-ATPase was carried out as previously de- 
scribed [30] and its activity calculated from the dialer- 
cncc in Pi release in the absence and prcscnce 01 
0.1 mM ouabain. The specific conditions of cxpcr- 
iments on drug interaction with the enzyme arc out- 
lined in the legends. 
Det~~~inarion Nf’ prorcin. Protein was determined 
by the method of Lowry c’f trl. [31]. 
KESC’LTS 
Churacterizurion of MCM jhx~im. The prep- 
aration was characteiized, and the reproducibility of 
the isolation procedure investigated by determining 
the specific activity of AChE, SDH and LDtr cell 
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content of Naf and K+, as well as the yield of pro- 
tein. The obtained mean values, expressed per mg of 
protein, were: 100 f 2 nmoles/min (AChE). 
18 f 2 nmoles/min (SDH), 240 & 20 nmoles/min 
(LDH), 49 k 14nEq (Na+) and 133 + 33 nEq (K+). 
The yield of protein was 17.6 f 1.4 mg/g of cortical 
wet weight. Specific activity (in units as above) of 
AChE in CM preparations from whole rat brain was 
reported as 161 [32] and 68 [33], whereas in purified 
synaptosomes it was 216 [32], 100 [34], 56 [33] and 
38 1351. The activity of SDH in mitochondria and 
in isolated synaptosomes was 305 and 148 nmolesimg 
of protein’min respectively [35]. LDH activity 
ranged from 117 nmoles/mg of protein. min in CM 
from whole rat brain [32] to 90 [34] and 305 
nmoles/mg of protein’min [32] in isolated synapto- 
somes. The reported yield of protein, per g of tissue 
wet weight, was 61 mg 1331 and 83 mg [32] in CM 
from whole rat brain, 23 mg in CM from rat cerebral 
cortex [36] and 11 mg [34], 1Omg [36] and 12mg 
[33] in isolated synaptosomes. 
The viability of the MCM fraction relating to study 
of transport processes, i.e. the presence of an intact 
plasma membrane [37], was ascertained by the un- 
changed cellular concentrations of Kf, Na+ and 
LDH (Fig. 1). Reported initial ratios of K+/Na+ in 
isolated synaptosomes ranged from 0.35 [38] to 1.51 
[39] and 4.75 1401. 
I/&Q of utilizing the MCMfractionfbr inuestigat- 
ing synaptosomal uptake processes. The possible con- 
tribution of mitochondria to data reflecting transport 
of biogenic amines in the MCM fraction was investi- 
gated using the following approach: (a) mitochondria 
were isolated by several procedures reported to result 
in little contamination by synaptosomes or other 
organelles; (b) the specific activity of SDH, used as 
mitochondrial marker, was determined in the mito- 
0 30 60 90 120 
Time of Storage at 0’ (ram) 
Time of Storage at O” (mid 
Fig. 1. Time dependence of cellular concentrations of 
LDH, K+ and Na+. After various times of storage at 0’ 
in 0.32 M sucrose, aliquots of the MCM fractions were 
added to the buffer medium and incubated for 15 min at 
LO Subsequently, LDH, K+ (M) and Na+ were 
determined as described in Materials and Methods. Results 
are averages of three experiments. 
I(I) ?5 ‘,I c 
chondrial fractions as well as in the MCM prep- 
aration; (c) total amount of protein was determined 
in the isolated mitochondria and expressed as per 
cent of the CM fraction from which they were separ- 
ated; (d) the uptake of 5-HT in the various isolated 
mitochondrial preparations and in the MCM fraction 
was determined: and (e) considering the results of 
protein determination. the uptake of 5-HT in the 
MCM fraction was compared with that obtained 
using the isolated mitochondria. 
The results of the above outlined experiments are 
shown in Table 1. From the obtained data, the magni- 
tude of possible contribution of mitochondria to the 
uptake of S-HT in the MCM preparation was deter- 
mined to be about 5 per cent. In addition to these 
experiments. the CM fraction was incubated with 
radiolabeled 5-HT and the preparation subsequently 
resolved by density gradient centrifugation into 
enriched synaptosomal and mitochondrial fractions, 
according to Gray and Whittaker 1211. The radioacti- 
vity in the latter two fractions corresponded to 90 
and 4 per cent of the total activity applied to the 
gradient. It should also be emphasized that in the 
MCM fraction used in this study the contamination 
by mitochondria was less than in the unmodified CM 
preparation. This was documented by the SDH speci- 
fic activity in the MCM fraction relative to the lower 
portion of the CM pellet: 18 and 39 nmoles/mg of 
protein. min respectively. 
Uptake of 5-HT und NE. The linear ranges of the 
uptake of biogenic amines are shown in Fig. 2, and 
the kinetics of the processes are presented in Figs. 
3 and 4. In view of the biphasic nature of 5-HT 
uptake, the initially obtained “masked’ values for 
both K, and V,,, were re-evaluated (Table 2) accord- 
ing to the method of Neal [41]. The latter correction 
takes into consideration the mutual interaction of the 
two processes, representing the low and high affinity 
uptake of 5-HT. 
The results on the uptake of DA were characterized 
by inconsistency, caused by low uptake rates. In view 
of the poor reproducibility of the uptake itself no 
attempts were made to investigate drug interaction 
with the latter process, 
Interaction IJ~’ drugs with the uptake qf 5-HT trrztl 
NE. The nature of drug interaction was analyzed 
graphically and the inhibition constants w’ere 
obtained from Dixon plots of the uptake of biogcnic 
amines in the presence of the drugs (Fig. 5). The Ki 
values are listed in Table 3. There was a general simi- 
larity in the pattern by which the investigated drugs 
inhibited the uptake of 5-HT and NE. K, values relat- 
ing to the low affinity uptake of 5-HT correlated well 
with inhibition constants of the drugs displayed in 
the uptake of NE. On the basis of their potency in 
inhibiting the uptake of both 5-HT and NE. all the 
investigated drugs could be divided into three distinct 
categories, characterized by K, values of: below 
12 /IM, between 20 and 50 AIM, and above 300,aM 
(Table 3). An exceptional effect was obtained with 
levorphanol, which inhibited 5-HT uptake with a Ki 
in the submicromolar range. Both levorphanol and 
dextrorphan displayed similar Ki values. Codeine, 
morphine and naloxone, on the other hand, affected 
both uptake processes least. Their interaction was 
characterized by high K, values, extending into the 
mM range particularly in inhibiting NE uptake. Both 
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Uptake of 5-HT Uptake of 5-HT in 
SDH activity M protein in fractiont MCM due to MT 
i 
nmoles (per cent of total pmoles (per cent of total 
my protem min 1 MCM protein) i ~~~~~ ‘~ mg protem min 1 uptake in fraction) 
106 5.x 0.16 0.7 
82 9.5 0.55 4.0 
53 13.5 0.42 4.4 
87 IO.0 0.97 7.5 
47 17.6 0.26 3.5 
MCM fraction 
(see Methods) 
18 <lO 1.29 <5 
* Presented results are averages of two to four experiments. 
t Conditions for uptake were as outlined in Methods. 
$ Numbers in this column were obtained by multiplying the results in columns 2 and 3 and dividing by 1.29, the 
value for 5-HT uptake in the MCM fraction. 
5-HT uptake and NE uptake were potently inhibited 
by quinacrine. 
Interaction of drugs with Na, K-ATPase. These 
studies were carried out with an enriched synaptoso- 
ma1 fraction, prepared according to Autilio rr ul. 1201. 
The mean specific activity of the enzyme in the prep- 
aration was 14.1 + 1.7 pmoles Pi/mg of protein. hr. 
The latter value represented 52 per cent of the total 





0 0.2 0.4 0.6 0.6 
(NE uptake) 
Protein (ma) 
reported values for the activity of Na, K-ATPasc tn 
purified synaptosomal fractions from whole rat brain 
were 4.5 [42], 8.4 [35] and 12.8 [34], whereas in 
synaptosomes from cerebral cortex the activity was 
6.4 [43], all expressed as pmoles Pi/mg of protein. hr. 
At concentrations of Na+ and K+ approximating 
those normally prevailing in an extracellular environ- 
ment, only three of the investigated drugs affected the 
Na, K-ATPase (Table 4). Among them methadone. 
at a concentration of 0.5 mM, was the most potent. 
inhibiting the enzyme 56 per cent. Further investiga- 
tion of the nature of methadone inhibition of synapto- 
somal ATPase revealed that the drug in inhibiting 
Na, K-ATPase partially blocked the ouabain site of 
the enzyme (Table 5). This was indicated by the extent 
of the protective effect of methadone displayed in 
Expt. 5 relative to the results in Expt. 4. As shown 
in Expt. 3, considering in addition Expts. 5 and 4. 
methadone also inhibited the Mg-activated ATPase 
component. 
l.Zr 
Fig. 2. Dependence of synaptosomal uptake of biogenic Fig. 3. Lineweaver-Burk plot of the uptake of 5-HT by 
amines on time and protein. The uptake of 5-HT (o-+) the MCM fraction. Plotted are the reciprocal initial con- 
and of NE (M) was determined as outlined in Mater- centrations of 5-HT in the medium against the reciprocal 
ials and Methods. In experiments on protein dependence rates of 5-HT uptake. The obtained values for K, and 
the uptake was terminated at times within the linear range. V,;,, are listed in Table 3. Presented are mean values of 
Shown are results of representative experiments. at least twenty experiments. 
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-10 -5 0 5 
I/ME 1 medium ‘O (2) 2o 25 
Fig. 4. Lineweaver-Burk plot of the uptake of NE by the 
MCM fraction. Plotted are the reciprocals of the initial 
concentrations of NE in the medium against the recipro- 
cals of the rates of NE uptake. The obtained values of 
K, and V,,, are listed in Table 3. Presented are mean 
values of at least twenty experiments. 
Changing the ion concentration in the assay 
medium, i.e. decreasing the ratio Na+/K+. diminished 
the extent of inhibition of Na, K-ATPase by metha- 
done (Table 5). As seen from Expts. 6-9, drug inhibi- 
tion of the enzyme was 22 per cent at a ratio of 
Na+/K+ equaling 1 as compared to 50 per cent if 
the latter was 20. The inhibition of Na, K-ATPase 
by methadone was reversible. Washing of synapto- 
somes with 50 mM imidazol.HCl, pH 7.0, almost 
completely restored the enzyme activity, initially inhi- 
bited by 0.5 mM methadone. 
DISCUSSION 
Since their discovery [21], synaptosomes have been 
increasingly used as conveniently available vesicular 
models to study biological phenomena in the synaptic 
region. Relating to transport processes, the synapto- 
somal uptake of biogenic amines [44] and amino 
acids [45,46] has been focused upon. An essential 
requirement in investigating cellular transport pro- 
cesses is the assertion of an intact plasma membrane 
in the preparation under study. In comparing various 
measures of viability in isolated cells, we recently de- 
scribed the cellular K+ content, or the ratio of cellu- 
lar K+ to cellular Na+, as most sensitive indicators 
of a nonleaking plasma membrane [37]. In the pres- 
ent study, synaptosomes further purified from the 
crude mitochondrial fraction displayed lower ratios 
I I 1 I I I I I I I J 
-25 -20 -I5 -IQ -5 0 5 IO 15 20 25 
Pento2ocinel~ t~.rM) 
Fig. 5. Dixon plot for the determination of inhibition con- 
stants. Plotted are the reciprocal rates of biogenic amine 
uptake against the concentration of inhibitor in the 
medium. K, is determined from the point of intersection 
of three lines, each describing the uptake process at differ- 
ent concentrations of biogenic amine. Presented are the 
results of a typical experiment showing the inhibition of 
the high affinity 5-HT uptake by pentazocine. 
of cellular K+/Na’ as compared to a modified crude 
mitochondrial fraction. Compared to the latter prep- 
aration, the inferior transport-related viability of puri- 
fied synaptosomes was also reflected in increased 
leakage of cellular LDH and did correlate with de- 
creased uptake rates for biogenic amines, as well as 
with poor reproducibility of the data. This finding 
is supported by the results of a recent study showing 
decreased uptake of GABA and glutamate in purified 
synaptosomes if compared to incubation of the sub- 
strates with the CM fraction and subsequent isolation 
of the synaptosomes 1473. 
Crude mitochondrial fractions have been frequently 
used in studies focusing on uptake processes in synap- 
tosomes (e.g. see Refs. 5. 7, 9 and 11). However, the 
use of such heterogeneous fractions requires the inves- 
tigation of possible contribution to the observed 
phenomena of mitochondria, the major nonsynapto- 
somal vesicles present. In the present work, the con- 
tribution of mitochondria to synaptosomal uptake of 
biogenic amines was extensively investigated and 
determined to be less than 5 per cent of the total 
observed uptake. A recent electron-microscopic study 
on the morphology of CM and purified synaptosomes 
revealed that the latter organelles accounted for 38 
per cent of all particles in either of the fractions [48]. 
In remarkedly good agreement with our finding relat- 




















* Presented are mean values of at least twenty determinations using different preparations of synapto- 
somes. The standard deviation around the mean was less than ?15 per cent. 
t Corrections were calculated according to Neal [41]. 
1262 A. L. CAHILL and F. MEDZIHRAVSKI 



















0.7 8 21 
1 .o 7 
4 IO 5 
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Y 9 2 
20 52 37 
18 30 32 
309 >1500 1300 
615 > 1500 1350 
807 > 1500 1120 
* Presented are averages of at least three determinations 
using different preparations of synaptosomes. The standard 
deviation of the mean was less than +lO per cent. 
ing to uptake (Table l), the free mitochondria in the 
CM fraction represented 7 per cent of all the vesicles 
present. Possible artifacts in the uptake experiments 
due to variable activity of monoaminooxydase, result- 
ing in deamination of the investigated compounds. 
were excluded by the demonstrated linearity of 
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* In this part of the work. purified sqnaptosomcs (frac- 
tion C. according to Autilio cf (I/. [ZO] were uacd. All 
values presented are averages of three experiments. except 
for methadone. which was investigated in nine experiments. 
The standard deviation around the mean was k7 per cent. 
t Synaptosomes were preincubated at 37 for 30 min 
with the particular drug. The assay of enzyme activity was 
started by the addition of ATP. 
uptake with synaptosomal protein. Additional evi- 
dence against such interference was presented by the 
linear kinetics of the Dixon plots. 
In order to establish a correlation with ongoing, 
transport-related studies in this laboratory, the synap- 
tosomal preparations in the present work were iso- 
Table 5. Characterization of methadone inhibition of ATPase* 
Experimental 
conditions Total 
Activity of ATPase 
(/tmoles Piimg protein.hr) 










60 min. -ouabain, 
-methadone 
60 min. +0.5 mM 
ouabain 
60 min. +0.5 mM 
methadone 
30 min. +O.S mM 
ouabain: 30 min. 
+0.5 mM ouabain, 
fO.5 mM methadone 
30 min. +O.S mM 
methadone; 30 min. 
+0.5 mM methadone. 
+ 0.5 mM ouabain 
IOU mM Na , 5 mM 
K’. - methadone 
100 mM Na-. 100 
mM K-. -methadone 
100 mM Na ’ 1 5 mM 
K *, +O.S mM mctha- 
done 
100 mM Nat. 100 mM 




























* After the preincubations at 37‘ as indicated, the assay of ATPase was started with ATP 
and was carried out as described in Methods. Data from Expts. l--5 indicate the site at which 
methadone interacts with Na, K-ATPase, whereas the results of Expts. &Y show the effect 
of ion concentration on drug inhibition of ATPase. The findings are interpreted in Results 
and Discussion. Presented are mean values of at least four experiments. The standard deviation 
around the mean was less than f IO per cent. 
t Figures in parentheses are per cent of controls. 
Interaction of CNS drugs with transport processes 7263 
lated from cerebral cortex. Until recently cerebral cor- 
tex was assumed to be lacking in dopaminergic 
neurons [49,50]. However, newer evidence [51-531 
contraindicates this concept describing the existence 
of DA nerve terminals in cortex, although limited to 
the limbic region [53]. In the present study, due to 
markedly low uptake rates and in agreement with the 
assumption of few dopaminergic terminals in cortex, 
a reproducible accumulation of DA in cortical synap- 
tosomes could not be established. 
The values for kinetic constants determined in this 
study are within the range reported for neuronal 
uptake of 5-HT and NE [I, 541. However, in 
numerous hitherto presented studies there was little 
consistency in presenting the kinetic data, e.g. the 
extent of drug interaction was expressed as per cent 
inhibition relative to control. In addition, the biphasic 
uptake of biogenic amines was often graphically 
“resolved” by simply extending the corresponding 
lines to obtain intercepts with the coordinates, result- 
ing in two pairs of kinetic constants. In doing so the 
mutual interaction of the two processes was neglected. 
leading to quite arbitrary numerical values, particu- 
larly regarding the kinetic constants of the high 
affinity uptake process (Table 2). 
Considering the viewpoint that the pharmacologic 
effect of various CNS drugs possibly represents the 
consequence of their interference in the synaptic 
uptake of biogenic amines, this study provides per- 
tinent data using a wide selection of CNS drugs stud- 
ied under identical conditions. In evaluating the inter- 
actions, the different magnitude of the inhibition con- 
stants was focused upon, ranging from submicromo- 
lar to mM concentrations. Both desipramine and 
amphetamine were potent inhibitors of biogenic 
amine uptake. An exceptional effect was obtained 
with levorphanol, which inhibited the high affinity 
5-HT uptake with a Ki of 0.7 /lM. The specificity of 
this effect is emphasized by the substantially lower 
potency of levorphanol in inhibiting the uptake of 
NE. The actions of levorphanol were not stereospeci- 
fit, as shown by the similar Ki value of dextrorphan. 
The high affinity binding of levorphanol in prep- 
arations from nervous tissue, reflecting the interaction 
with a narcotic receptor. has been shown to be ster- 
eospecific [55,56]. Relating to narcotic drugs, it is 
of interest to note the rather strong inhibitory poten- 
cies displayed by methadone and pentazocine as 
opposed to the weak effects of morphine, codeine and 
naloxone. The distinctly high K, values of the latter 
drugs present a strong argument against a biologic 
role of their interaction with the synaptosomal trans- 
port of biogenic amines in cerebral cortex. 
In comparing the inhibitory pattern of the drugs 
in the present work with pertinent results of previous 
studies, one is hampered by the following differences: 
source of synaptosomes, number of drugs studied un- 
der identical conditions, and lack of a common 
method in expressing drug inhibition of biogenic 
amine uptake. Previous studies have particularly 
focused upon the effects of tricyclic antidepressants 
and amphetamine on the uptake of 5-HT [3,5] and 
NE [7,9]. Amphetamine inhibited both the high and 
low affinity uptake of 5-HT with a Ki of 7pM [S], 
which agrees with the finding in this study, showing 
similar Ki values for this drug in inhibiting both 
uptake processes for 5-HT. Also in good agreement 
with results in Table 3 is the lczo of 6pM reported 
for desipramine in inhibiting 5-HT uptake in crude 
synaptosomal preparations from whole rat brain [4]. 
On the other hand, our results disagree with the pre- 
viously reported inhibition by methadone of synapto- 
somal 5-HT uptake [6]. Whereas in that study mor- 
phine exhibited a Ki of 400 PM. a value approximat- 
ing that shown in Table 3, methadone had a Ki of 
1 nM as opposed to 28 I’M determined in the present 
work. Despite the differences in species (rabbit vs rat) 
and in brain regions (whole brain vs cerebral cortex), 
the discrepancy in the effects of morphine and metha- 
done in the two studies is puzzling. Previously, the 
same laboratory reported morphine, methadone, the- 
baine and codeine to be potent inhibitors of synapto- 
somal NE uptake at concentrations between 0.2 and 
2mM [S]. In addition to the markedly high concen- 
trations of the drugs, morphine in that study was 
reported as more potent in inhibiting NE uptake than 
methadone. The study did not include K, values. 
These findings [S] again disagree with our observd- 
tion that morphine, codeine and naloxone were mark- 
edly weak inhibitors of NE uptake as compared to 
the other CNS drugs investigated. On the other hand, 
our results correlate well with the order of potency 
according to which narcotics, including morphine and 
methadone, inhibited NE uptake in a different study 
[lo]. In that work, the Ki values for morphine, 
codeine and naloxone were higher by 2 magnitudes 
than those for methadone and levorphanol. An ad- 
ditional study showed significant inhibition of synap- 
tosomal NE uptake by 0.1 to 1 mM concentrations 
of morphine [ll]. The reported effects of tricyclic 
antidepressants on NE uptake [7,9] are in good 
agreement with the results shown in Table 3, as exem- 
plified by Ki values of 8 PM for amitriptyline [7] and 
5 /*M for desipramine 141. 
In evaluating drug interaction in this study, the 
potent effect of quinacrine in inhibiting both 5-HT 
and NE uptake is of interest. This compound proved 
to be a strong inhibitor of the transport of drugs in 
leukocytes [I& 191. the isolated retina 1573 and in 
brain slices (Medzihradsky and Lin. unpublished ob- 
servations). Quinacrine is apparently recognized as 
a substrate by uptake systems for basic amines. trans- 
port processes characterized by limited structural 
specificity and seemingly wide distribution in mam- 
malian tissue [I 77191. 
The low affinity uptake of 5-HT has been assumed 
to be due to noradrenergic and/or dopaminergic 
neuronal uptake sites [l, 2,541. The inhibition pattern 
of the drugs investigated here presents strong evi- 
dence in support of this assumption: the Ki values 
relating to the low affinity uptake of 5-HT were simi- 
lar to those obtained for the uptake of NE. 
Inhibition of CNS drugs of the enzyme coupled 
to the transmembrane transport of Na’ and K+ 
could reflect a possible mode of action of these com- 
pounds, due to induced changes in the concentration 
of monovalent ions in the synaptic cleft. However. 
at typical extracellular concentrations of Na+ and K + 
likely to reflect the ion content in the synaptic cleft 
C581. only methadone at submillimolar concen- 
trations showed substantial and reversible inhibition 
of Na, K-ATPase. Although the effect was obtained 
with 0.5 mM drug, this relatively high concentration 
is within the range of those applied in previous 
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reports demonstrating partial inhibition of synaptoso- 
mal Na. K-ATPase by chlorpromazine and haloperi- 
dol 1143. and tricyclic anti-depressants [ 14, 151. In 
these studies. the effective concentration of the drugs 
was in the range of 0.1 to I mM. Tissue levels of 
basic amines. like methadone. can be expected to be 
considerably higher than their therapeutic concen- 
tration in plasma. As shown previously, among the 
drugs investigated here and at similar concentrations, 
desipramine and pentazocine inhibited by 40 and 15 
per cent an enriched preparation of Na, K-ATPase 
from brain 1591. 
Changing the ion concentration in the direction 
which reflected synaptic K+ release, i.e. at a decreased 
ratio of Na+,/K+ in the assay, markedly diminished 
the extent of enzyme inhibition. This finding indicates 
limited effect of the drug on the active reuptake of 
K+. involving the Na, K-ATPase, after synaptic dis- 
charge. The protective effect of K +. as well as results 
of the cross-inhibition experiments suggested partial 
involvement of the ouabain site in the interaction of 
methadone with Na. K-ATPase and also indicated 
inhibition by the drug of Mg-ATPase. 
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